-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Cero Therapeutics Holdings, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from Q2 2021 to Q1 2023.
- Cero Therapeutics Holdings, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$198K, a 35.8% increase year-over-year.
- Cero Therapeutics Holdings, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$1.52M, a 39.5% decline from 2022.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)